Top-News
ist da eine dividende is aussicht?
Beiträge: 25
Zugriffe: 6.685 / Heute: 1
Zugriffe: 6.685 / Heute: 1
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers MSCI Japan UCITS ETF 1D
Perf. 12M: +155,87%
Xtrackers MSCI Pakistan Swap UCITS ETF 1C
Perf. 12M: +68,36%
Xtrackers Artificial Intelligence and Big Data UCITS ETF 1C
Perf. 12M: +57,05%
Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C
Perf. 12M: +53,56%
Xtrackers MSCI USA Communication Services UCITS ETF 1D
Perf. 12M: +51,49%
"Terms of the sale include a one-time payment of $7MM. The perpetual license agreement is anticipated to be signed within 30 days, pending the results of a due diligence study by the intended buyer."
also der vertrag ist noch nicht unterschrieben aber die planen eine dividende falls das geschäft mit dem käufer zustande kommt oder wie?
und wenn der käufer alles abblässt dann gibs nix ? ist wohl eher ein zock in der aktie eine wette darauf das der deal zustande kommt meiner meinung nach wer hier heute aktien gekauft hat.
vielleicht hab ichs auch falsch vertsanden vielleicht weis jemand besser bescheid?
also der vertrag ist noch nicht unterschrieben aber die planen eine dividende falls das geschäft mit dem käufer zustande kommt oder wie?
und wenn der käufer alles abblässt dann gibs nix ? ist wohl eher ein zock in der aktie eine wette darauf das der deal zustande kommt meiner meinung nach wer hier heute aktien gekauft hat.
vielleicht hab ichs auch falsch vertsanden vielleicht weis jemand besser bescheid?
Medisafe 1 Technologies Obtains Listing on Berlin Stock Exchange
16:40 24.09.12
PR Newswire
JERUSALEM, September 24, 2012
JERUSALEM, September 24, 2012 /PRNewswire/ --
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's common stock became eligible for trading on the Borse Berlin, or the Berlin Stock Exchange, under the symbol "MS1" and the German security number (WKN) "A1JPAQ".
The Berlin Stock Exchange has secondary stock listings for over 6,000 U.S. securities that are listed on such exchanges as the NYSE, NASDAQ, AMEX or quoted on the OTC Bulletin Board.
"Trading shares on the Berlin exchange provides Medisafe 1 Technologies with increased exposure to the European capital markets," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "We are hopeful that access to additional investment capital can increase the company's capabilities to further develop and market our proprietary, life-saving devices."
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at www.sec.gov.
Contact:
Jacob Elhadad CEO
+972-524440000
Jacob.elhadad10@gmail.com
SOURCE Medisafe 1 Technologies Corp.
Quelle: PR Newswire
16:40 24.09.12
PR Newswire
JERUSALEM, September 24, 2012
JERUSALEM, September 24, 2012 /PRNewswire/ --
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's common stock became eligible for trading on the Borse Berlin, or the Berlin Stock Exchange, under the symbol "MS1" and the German security number (WKN) "A1JPAQ".
The Berlin Stock Exchange has secondary stock listings for over 6,000 U.S. securities that are listed on such exchanges as the NYSE, NASDAQ, AMEX or quoted on the OTC Bulletin Board.
"Trading shares on the Berlin exchange provides Medisafe 1 Technologies with increased exposure to the European capital markets," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "We are hopeful that access to additional investment capital can increase the company's capabilities to further develop and market our proprietary, life-saving devices."
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at www.sec.gov.
Contact:
Jacob Elhadad CEO
+972-524440000
Jacob.elhadad10@gmail.com
SOURCE Medisafe 1 Technologies Corp.
Quelle: PR Newswire
dividende bezahlen .....naja mitte oktober ist man schlauer hier entweder deal done oder deal geplatzt
nur meine meinung...
nur meine meinung...
http://www.ariva.de/news/...losing-7MM-Perpetual-License-Sale-4310709
Update to Medisafe 1 Technologies Corp.SHAREHOLDERS: Due Diligence Complete Prior to Closing $7MM Perpetual License Sale
14:35 24.10.12
PR Newswire
JERUSALEM, October 24, 2012
JERUSALEM, October 24, 2012 /PRNewswire/ --
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that due diligence by both parties to the sale has been successfully completed, and the sale is expected to be finalized and initiated by November 5 2012.
The agreement will transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system to a third party. Terms of the sale include a $7MM payment to Medisafe 1 Technologies.
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.
Contact:
Jacob Elhadad, CEO
+972-524440000
Jacob.elhadad10@gmail.com
Update to Medisafe 1 Technologies Corp.SHAREHOLDERS: Due Diligence Complete Prior to Closing $7MM Perpetual License Sale
14:35 24.10.12
PR Newswire
JERUSALEM, October 24, 2012
JERUSALEM, October 24, 2012 /PRNewswire/ --
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that due diligence by both parties to the sale has been successfully completed, and the sale is expected to be finalized and initiated by November 5 2012.
The agreement will transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system to a third party. Terms of the sale include a $7MM payment to Medisafe 1 Technologies.
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.
Contact:
Jacob Elhadad, CEO
+972-524440000
Jacob.elhadad10@gmail.com
"due diligence by both parties to the sale has been successfully completed, and the sale is expected to be finalized and initiated by November 5 2012."
bleibt also spannend hier...schau ma mal
bleibt also spannend hier...schau ma mal
Medisafe 1 Technologies Records an Operating Profit of Approximately $2M in the Fourth Fiscal Quarter of 2012
ih.advfn.com/p.php?pid=nmona&article=55828982
ih.advfn.com/p.php?pid=nmona&article=55828982
"Upon the completion of this non-exclusive perpetual license agreement, we will be extremely pleased to be able to reward our shareholders with this special dividend," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "Similarly, we intend to continue to update our shareholders with further information following the sale's closing."
ih.advfn.com/p.php?pid=nmona&article=558289
na da kann man doch mal gespannt sein
ih.advfn.com/p.php?pid=nmona&article=558289
na da kann man doch mal gespannt sein
Wird hier eine Dividende ausgezahlt?
Wenn ja, da hört sich gut an.
Medisafe 1 Technologies erwirtschaftet einen operativen Gewinn von rund $ 2M in das vierte Quartal des Jahres 2012.
Quelle: http://finance.yahoo.com/news/medisafe
Wenn ich mir den Jahreschart so ansehe, wird der Kurs aus charttechnischer Sicht in paar Monaten bei 0.015 US$ stehen. Sieht nach einem schönen "W" aus.
Ist nur meine Meinung und keine Kaufempfehlung.
die reden schon fast seit einen halben jahr von möglichen dividenden...ich komm mir schon richtig verkackeiert vor....naja abwarten was hier noch passiert oder auch nicht.
@ pennystocktr. >> Eine Dividende wird am Jahresanfang ausgezahlt.
Auch das sollte man beachten, deswegen sehen wir bald Cent-Beträge bei MFTH:
finance.yahoo.com/news/medisafe-1-technologies-signs-7mm-140000940.html
Meiner Meinung nach startet MFTH morgen auf die 0.0045/0.0050 US$.
Charttechnisch sieht es jedenfalls danach aus...
Wer heute nicht einsteigt, wird wohl nächte Woche nur noch hinterher rennen. Umsatz steigt,2 Mio.$ Gewinn im 4. Quartal 2012 und die MK liegt immer noch unter 2 Mio. $.
aktuell 0.0034 $
Kursziel 0.015 $
Nur meine Meinung.
Das Unternehmen plant eine einmalige Sonderdividende an alle bestehenden Aktionären im Rahmen einer unbefristeten Lizenzvereinbarung mit SAFECODE DRUG TECHNOLOGIES CORP.
Quelle Kaufempfehlung: http://www.nismagazine.com
ih.advfn.com/...chart&s=NB^MFTH&p=0&t=19&vol=1
fein
fein
... und so geht es schrittweise immer weiter
beim nächsten sprung werd ich die aber wieder verkaufen fals noch einer kommen sollte. ich hatte die aktie im sommer bei 0,006$ gekauft zwischendurch war sie fast runter bis auf 0,0016$ nun wieder erholt auf 0,0037$ . naja schau ma mal
Hat jemand schon die Dividende erhalten? Zahltag soll ja der 06.05. gewesen sein!
... da sind die Anleger wohl mal wieder schön verar..... wurden, von wegen 1c Dividende.
Ha, ha ...
Ha, ha ...
Neueste Beiträge aus dem Medisafe 1 Tech Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 24 | ist da eine dividende is aussicht? | pennystocktrader | reza66 | 14.05.13 14:45 |
